English

Chinese English

HOME / ABOUT US

Koehler Pharmaceuticals (Beijing) Ltd. is a Joint Venture company established in 2020 by Dr. Franz Köhler Chemie GmbH with partners in China. The company will centrally manage and operate the business of CUSTODIOL for cardiac- and transplant surgery in the Chinese market, aim at providing better, faster and more attentive services to Chinese hospitals and clinicians, as well as advanced support for Chinese patients’ health.

CUSTODIOL is worldwide used and known as the original HTK-Bretschneider solution, which is also the standard as cardioplegic and organ protective solution in thoracic surgery and organ transplantation. It has been accepted and used in more than 90 countries worldwide and greatly appreciated in variety of different markets throughout the world.

The company will continue the mission of Dr. Franz Koehler Chemie GmbH in regarding to promoting medical science and research, dedicating to conduct further research on myocardial protection and organ preservation together with clinical experts in China, and introducing more outstanding products for intensive care medicine into the China market.

About Dr. Franz Koehler Chemie GmbH, Germany

Dr. Franz Koehler Chemie GmbH (www.koehler-chemie.de) is a Family-owned and managed pharmaceutical company with long history and experience. Founded in 1959, the company is specialized in organ preservation solutions, therapeutics for intensive care medicine, antidotes and x-ray contrast agents. With its highly specialized portfolio of niche products in the field of organ-protecting solutions, the company has gained market leadership through its profound long term know-how and tremendous responsibility. The organ-protecting solutions are predominantly applied in the open heart surgery and in organ transplantations.

The company has its own research and development center, where numerous interdisciplinary joint projects are developed with internationally renowned universities and hospitals. As a result, research and pharmaceutical production benefit equally from an effective and demand oriented organization – to profit the patient and the physician. The products are being manufactured in Germany with state-of-the-art technology and according to the high national and international quality standards under GMP conditions, with the capacity of more than 6.000 litres/day.

The company has grown into an innovative and research driven pharmaceutical company with Partners and Distribution network all over the world.